Literature DB >> 31245106

Terlipressin or norepinephrine in septic shock: do we have the answer?

Mark D Williams1, James A Russell2.   

Abstract

Entities:  

Year:  2019        PMID： 31245106      PMCID： PMC6560608          DOI： 10.21037/jtd.2019.05.07

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  26 in total

1.  Terlipressin--more than just a prodrug of lysine vasopressin?

Authors:  Martin Westphal; Sebastian Rehberg; Christian Ertmer; Andrea Morelli; Morelli Andrea
Journal:  Crit Care Med       Date:  2009-03       Impact factor: 7.598

Review 2.  "Terlipressin in the treatment of septic shock: the earlier the better"?

Authors:  Andrea Morelli; Christian Ertmer; Martin Westphal
Journal:  Best Pract Res Clin Anaesthesiol       Date:  2008-06

3.  Comparison of dopamine and norepinephrine in the treatment of shock.

Authors:  Daniel De Backer; Patrick Biston; Jacques Devriendt; Christian Madl; Didier Chochrad; Cesar Aldecoa; Alexandre Brasseur; Pierre Defrance; Philippe Gottignies; Jean-Louis Vincent
Journal:  N Engl J Med       Date:  2010-03-04       Impact factor: 91.245

4.  Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study.

Authors:  Andrea Morelli; Christian Ertmer; Sebastian Rehberg; Matthias Lange; Alessandra Orecchioni; Valeria Cecchini; Alessandra Bachetoni; Mariadomenica D'Alessandro; Hugo Van Aken; Paolo Pietropaoli; Martin Westphal
Journal:  Crit Care       Date:  2009-08-10       Impact factor: 9.097

Review 5.  Terlipressin: a promising vasoactive agent in hemodynamic support of septic shock.

Authors:  Andrea Morelli; Christian Ertmer; Paolo Pietropaoli; Martin Westphal
Journal:  Expert Opin Pharmacother       Date:  2009-10       Impact factor: 3.889

6.  Role of arginine vasopressin and terlipressin as first-line vasopressor agents in fulminant ovine septic shock.

Authors:  Sebastian Rehberg; Christian Ertmer; Gabriele Köhler; Hans-Ulrich Spiegel; Andrea Morelli; Matthias Lange; Katharina Moll; Katrin Schlack; Hugo Van Aken; Fuhong Su; Jean-Louis Vincent; Martin Westphal
Journal:  Intensive Care Med       Date:  2009-04-10       Impact factor: 17.440

7.  Vasopressin versus norepinephrine infusion in patients with septic shock.

Authors:  James A Russell; Keith R Walley; Joel Singer; Anthony C Gordon; Paul C Hébert; D James Cooper; Cheryl L Holmes; Sangeeta Mehta; John T Granton; Michelle M Storms; Deborah J Cook; Jeffrey J Presneill; Dieter Ayers
Journal:  N Engl J Med       Date:  2008-02-28       Impact factor: 91.245

8.  Effects of short-term simultaneous infusion of dobutamine and terlipressin in patients with septic shock: the DOBUPRESS study.

Authors:  A Morelli; C Ertmer; M Lange; M Dünser; S Rehberg; H Van Aken; P Pietropaoli; M Westphal
Journal:  Br J Anaesth       Date:  2008-02-27       Impact factor: 9.166

9.  A comparison of epinephrine and norepinephrine in critically ill patients.

Authors:  John A Myburgh; Alisa Higgins; Alina Jovanovska; Jeffrey Lipman; Naresh Ramakrishnan; John Santamaria
Journal:  Intensive Care Med       Date:  2008-07-25       Impact factor: 17.440

10.  Role of selective V2-receptor-antagonism in septic shock: a randomized, controlled, experimental study.

Authors:  Sebastian Rehberg; Christian Ertmer; Matthias Lange; Andrea Morelli; Elbert Whorton; Martin Dünser; Anne-Katrin Strohhäcker; Erik Lipke; Tim G Kampmeier; Hugo Van Aken; Daniel L Traber; Martin Westphal
Journal:  Crit Care       Date:  2010-11-05       Impact factor: 9.097
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.